MedTrace Logo

Brief Single-Session Body Neutrality Program for LGBTQ+ Adults in Central Alabama

NCT07621081 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-02

No results posted yet for this study

Summary

LGBTQ+ individuals tend to have elevated risks for eating disorders (ED), possibly due to minority stress. For LGBTQ+ individuals living in rural Alabama, they tend to experience high levels of anti-LGBTQ+ structural stigma and limited access to LGBTQ+-specific resources, which engender compounded risk for ED development and reduced access to care. Brief digital single-session intervention that incorporates psychoeducation about minority stress and body neutrality may be efficacious in reducing ED risk and improve positive body image among LGBTQ+ adults in rural areas. Prior research from another lab developed a single-session intervention (Project Body Neutrality) among LGBTQ+ adolescents indicated immediate positive changes in body image constructs and psychological well-being. The present project evaluates and adapts Project Body Neutrality, specifically for LGBTQ+ adults in a rural high-stigma, low-resource region.

Conditions

  • Body Image

Interventions

BEHAVIORAL

Single session body neutrality program

Single session body neutrality program is a brief, 30-minute digital intervention program. Participants will at first be given a brief introduction to body neutrality and minority stress. Then, they will be given fictional vignettes of based on common regional examples of body image stressors for LGBTQ+ individuals and practice giving advice to them. Finally, participants are provided with their customized body neutrality action plan based on their responses during the intervention program.

Sponsors & Collaborators

  • Auburn University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-02
Primary Completion
2028-08-02
Completion
2028-08-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07621081 on ClinicalTrials.gov